Patent details

EP3156422 Title: HIGH AFFINITY HUMAN ANTIBODIES TO PCSK9

Basic Information

Publication number:
EP3156422
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP162003057
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
HIGH AFFINITY HUMAN ANTIBODIES TO PCSK9
French Title of Invention:
ANTICORPS HUMAINS À GRANDE AFFINITÉ POUR LE PCSK9
German Title of Invention:
HOCHAFFINE MENSCHLICHE ANTIKÖRPER GEGEN PCSK9
SPC Number:

Dates

Filing date:
15/12/2009
Grant date:
25/08/2021
EP Publication Date:
19/04/2017
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/08/2021
EP B1 Publication Date:
25/08/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
15/12/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/08/2021
 
 

Name:
Regeneron Pharmaceuticals, Inc.
Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)

Agent

Name:
ARONOVA S.A.
From:
24/11/2021
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
HUANG, Tammy, T.
Address:
United States (US)

2

Name:
MACDONALD, Douglas
Address:
United States (US)

3

Name:
MARTIN, Joel H.
Address:
United States (US)

4

Name:
SLEEMAN, Mark W.
Address:
Australia (AU)

Priority

1

Priority Number:
122482 P
Priority Date:
15/12/2008
Priority Country:
United States (US)

2

Priority Number:
210566 P
Priority Date:
18/03/2009
Priority Country:
United States (US)

3

Priority Number:
168753 P
Priority Date:
13/04/2009
Priority Country:
United States (US)

4

Priority Number:
218136 P
Priority Date:
18/06/2009
Priority Country:
United States (US)

5

Priority Number:
249135 P
Priority Date:
06/10/2009
Priority Country:
United States (US)

6

Priority Number:
261776 P
Priority Date:
17/11/2009
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/40; C12N 9/64; A61K 39/395; A61P 3/06;

Publication

European Patent Bulletin

Issue number:
202134
Publication date:
25/08/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/12/2025
Annual Fee Number:
17
Annual Fee Amount:
246 Euro
Expected Payer:
Last Annual Fee Payment Date:
28/11/2024
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
230 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
24/11/2021 Power Of Attorney 1
24/11/2021 Outgoing Correspondence 1